SR One, AbbVie Ventures, Takeda Ventures and Pfizer Ventures all returned having already backed the cancer and inflammatory disease drug developer at series A stage.

The healthcare-focused workplace management software provider hiked its total funding to about $225m as Ascension Ventures reinvested.

Evolution Media and new investor Amazon Alexa Fund helped home fitness product developer Tonal hike its overall funding to $200m.

Digital China Holdings' big data services spinoff has raised funding from two state-owned investment entities at a $918m valuation.

SR One, AbbVie Ventures, Takeda Ventures and Pfizer Ventures all returned for the cancer and inflammatory disease drug developer's series B.

Bonnier contributed to the $170m first close of a the urban farming technology developer's series C round, taking its debt and equity financing to at least $305m.

Amazon Alexa Fund and Specialized Bicycle Components vehicle Zone 5 Ventures helped the social exercise platform raise money at a valuation above $1bn.

China Life has returned for a $142m series D-plus round for cancer treatment developer Biocytogen, having already co-led its $77m series D round 13 months ago.

Syncona, Jeito Capital and EcoR1 Capital have co-led the Netherlands Cancer Institute-founded Neogene Therapeutics' series A round.

The Tencent-backed fantasy sports provider has secured primary and secondary investment at a reported valuation topping $2.5bn.